These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 6864519

  • 1. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1983 Jun; 225(3):546-52. PubMed ID: 6864519
    [Abstract] [Full Text] [Related]

  • 2. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [Abstract] [Full Text] [Related]

  • 3. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
    [Abstract] [Full Text] [Related]

  • 4. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N, Kamata Y, Simpson LL.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1994 Apr; 269(1):256-62. PubMed ID: 8169833
    [Abstract] [Full Text] [Related]

  • 6. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin.
    Simpson LL.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological experiments on the binding and internalization of the 50,000 dalton carboxyterminus of tetanus toxin at the cholinergic neuromuscular junction.
    Simpson LL.
    J Pharmacol Exp Ther; 1985 Jul; 234(1):100-5. PubMed ID: 2409271
    [Abstract] [Full Text] [Related]

  • 8. Identification of the site at which phospholipase A2 neurotoxins localize to produce their neuromuscular blocking effects.
    Simpson LL, Lautenslager GT, Kaiser II, Middlebrook JL.
    Toxicon; 1993 Jan; 31(1):13-26. PubMed ID: 8446959
    [Abstract] [Full Text] [Related]

  • 9. The interaction between aminoquinolines and presynaptically acting neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1982 Jul; 222(1):43-8. PubMed ID: 6283072
    [Abstract] [Full Text] [Related]

  • 10. Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.
    Simpson LL.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):600-4. PubMed ID: 6707911
    [Abstract] [Full Text] [Related]

  • 11. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL, Dasgupta BR.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [Abstract] [Full Text] [Related]

  • 12. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.
    Kalandakanond S, Coffield JA.
    J Pharmacol Exp Ther; 2001 Mar; 296(3):980-6. PubMed ID: 11181932
    [Abstract] [Full Text] [Related]

  • 13. The binary toxin produced by Clostridium botulinum enters cells by receptor-mediated endocytosis to exert its pharmacologic effects.
    Simpson LI.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1223-8. PubMed ID: 2600812
    [Abstract] [Full Text] [Related]

  • 14. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B.
    Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
    [Abstract] [Full Text] [Related]

  • 15. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S, Bartoszcze M, Gryko R.
    Przegl Epidemiol; 2007 Feb; 61(3):519-27. PubMed ID: 18069389
    [Abstract] [Full Text] [Related]

  • 16. Mode of action of tetanus toxin on the neuromuscular junction.
    Parsons RL, Hofmann WW, Feigen GA.
    Am J Physiol; 1966 Jan; 210(1):84-90. PubMed ID: 5903147
    [No Abstract] [Full Text] [Related]

  • 17. Neuropharmacological characterization of fragment B from tetanus toxin.
    Simpson LL, Hoch DH.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):223-7. PubMed ID: 3965693
    [Abstract] [Full Text] [Related]

  • 18. Influence of temperature upon paralyzing and myotoxic effects of bothropstoxin-I on mouse neuromuscular preparations.
    Cavalcante WL, Silva MD, Gallacci M.
    Chem Biol Interact; 2005 Jan 15; 151(2):95-100. PubMed ID: 15698581
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type A: kinetics of calcium dependent paralysis of the neuromuscular junction and antagonism by drugs and animal toxins.
    Metezeau P, Desban M.
    Toxicon; 1982 Jan 15; 20(3):649-54. PubMed ID: 6125045
    [Abstract] [Full Text] [Related]

  • 20. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR, Marvaud JC, Raffestin S.
    Ann Pharm Fr; 2001 May 15; 59(3):176-90. PubMed ID: 11427819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.